PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Ciclosporin 0.05% Eye Drops - Dry eyes
PAD Profile : Ciclosporin 0.05% Eye Drops - Dry eyes
Brand Names Include :
Restasis, Optimmune 0.2%
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
Other Indications
- Dermatology indications
- Psoriatic arthritis
- Gastroenterology indications
- Dry eyes
- Neurology indications
- Uveitis
- Renal indications
- Rheumatology indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
06 July 2016
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Restatis (ciclosporin 0.05% eye drops) is considered to be a RED drug and initiation and continuation of supply should be from a specialist clinician.
The local guidance below was updated in December 2016 in relation to ciclosporin preparations following the publication of NICE guidance for Ikervis (ciclosporin 1% eye drops)
Associated BNF Codes
11. Eye
11.08.01. Tear deficiency, eye lubricant and astringent